Almaject

Almaject is a pharmaceutical company specializing in the development and commercialization of generic injectable products for the U.S. market. Operating as a subsidiary of Alvogen, the company focuses on providing high-quality, affordable alternatives to branded institutional medicines. Their portfolio spans several critical therapeutic areas, including oncology, anti-infectives, and anesthesia. Almaject leverages a global supply chain and robust regulatory expertise to ensure a consistent supply of essential medications to hospitals and healthcare providers. The company is committed to expanding its pipeline with complex generics and value-added injectable therapies.